Table 7.
Trough levels of total immunoglobulin (Ig)G at the end of treatment periods
| Treatment (interval) | n | Geometric mean (95% CI) | Median (95% CI) | Min; max | |
|---|---|---|---|---|---|
|
IGIV 10% (4 weeks) |
End of period 1 | 27 | 7·20 (6·54–7·93) | 7·45 (6·29–8·05) | 4·27; 12·75 |
|
IGSC 16% (1 week) |
End of period 1 | 14 | 8·97 (7·77–10·35) | 9·53 (7·78–11·31) | 5·41; 12·28 |
|
IGSC 20% (1 week) |
Week 21–27 | 46 | 8·73 (8·13–9·38) | 8·48 (7·94–9·90) | 5·17; 13·25 |
| End of period 2 | 40 | 8·27 (7·48–9·13) | 8·26 (7·30–8·96) | 4·27; 15·87 | |
95% CI = 95% confidence interval. IGIV = intravenous immunoglobulin; IGSC = subcutaneous immunoglobulin.